FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paolo Bruzzi

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Italy

Co-author Network

Publications

TOP 3
Lucia Del Mastro; Antonio Durando; Alessandra Fabi; Gbenga Kazeem; Ignazia La Torre; Mauro Mansutti; Paolo Marchi; Domenico Franco Merlo; Marco Venturini; Davide Boy; Paolo Bruzzi; Matteo Ceccarelli; Michele De Laurentiis; Sabino De Placido; Francesco Cognetti
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments.
Maria Pia Sormani; Paolo Bruzzi
Reporting of subgroup analyses from clinical trials.
Bernardo Bonanni; Paolo Bruzzi; Massimiliano Cazzaniga; Valentina Aristarco; Fabio Bassi; Viviana Galimberti; Alessandra Gennari; Aliana Guerrieri-Gonzaga; Harriet Johansson; Matteo Lazzeroni; Alberto Luini; Giancarlo Pruneri; Matteo Puntoni; Davide Serrano; Maria Stella Trabacca; Clara Varricchio; Paolo Veronesi; Giuseppe Viale; Andrea Decensi
Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paolo Bruzzi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lucia Del Mastro; Antonio Durando; Alessandra Fabi; Gbenga Kazeem; Ignazia La Torre; Mauro Mansutti; Paolo Marchi; Domenico Franco Merlo; Marco Venturini; Davide Boy; Paolo Bruzzi; Matteo Ceccarelli; Michele De Laurentiis; Sabino De Placido; Francesco Cognetti
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments.
BMC cancer 2013;13():164.
2012: Maria Pia Sormani; Paolo Bruzzi
Reporting of subgroup analyses from clinical trials.
Lancet neurology 2012;11(9):747; author reply 747-8.
2012: Bernardo Bonanni; Paolo Bruzzi; Massimiliano Cazzaniga; Valentina Aristarco; Fabio Bassi; Viviana Galimberti; Alessandra Gennari; Aliana Guerrieri-Gonzaga; Harriet Johansson; Matteo Lazzeroni; Alberto Luini; Giancarlo Pruneri; Matteo Puntoni; Davide Serrano; Maria Stella Trabacca; Clara Varricchio; Paolo Veronesi; Giuseppe Viale; Andrea Decensi
Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(21):2593-600.
2012: Sergio Bertoglio; Maura Bonvento; Paolo Meszaros; Simona Pastorino; Nicola Solari; Francesca Vassallo; Paolo Bruzzi
Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients.
Cancer nursing 2012;35(4):E35-42.
2011: Maria Pia Sormani; B Stubinski; Paolo Bruzzi; P Cornelisse; D K Li; Sanda Rocak; N De Stefano
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.
Neurology 2011;77(18):1684-90.
2011: Giuseppe Canavese; F Carli; Paolo Bruzzi; Lucia Del Mastro; Beatrice Dozin; A Levaggi; C Rossello; S Spinaci; Daniela Tomei; Carlo Vecchio; Giuseppe Villa; Alessandra Catturich
Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2011;37(8):688-94.
2011: Maria Pia Sormani; Paolo Bruzzi; Gian Luigi Mancardi
Comments on "evidence for acute neurotoxicity after chemotherapy".
Annals of neurology 2011;69(6):1064; author reply 1064-5.
2010: Giuseppe Canavese; Paolo Bruzzi; Alessandra Catturich; Carlo Vecchio; Daniela Tomei; F Carli; M Truini; G B Andreoli; V Priano; Beatrice Dozin
Intra-operative evaluation of the sentinel lymph node for T1-N0 breast-cancer patients: always or never? A risk/benefit and cost/benefit analysis.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2010;36(8):737-44.
2010: Patrizia Piccioli; Giuseppe Balbi; Martina Serra; Anna Morabito; Teresa Lamparelli; marco gobbi; Stefania Laurent; Beatrice Dozin; Paolo Bruzzi; Anna Maria Ferraris; Andrea Bacigalupo; Rosario Notaro; Maria Pia Pistillo
CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.
Annals of hematology 2010;89(6):613-8.
2009: Giovanni B Ratto; Roberta Costa; Paola Maineri; Antonella Alloisio; Paolo Bruzzi; Beatrice Dozin
Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?
The Journal of thoracic and cardiovascular surgery 2009;138(4):849-58.
2009: Maria Pia Sormani; Laura Bonzano; Luca Roccatagliata; Gary R Cutter; Giovanni Luigi Mancardi; Paolo Bruzzi
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.
Annals of neurology 2009;65(3):268-75.
2008: Valentina Guarneri; Antonio Frassoldati; Paolo Bruzzi; Roberto D'Amico; Maurizio Belfiglio; Annamaria Molino; Oscar Bertetto; Stefano Cascinu; Francesco Cognetti; Angelo Di Leo; Paolo Pronzato; Lucio Crinó; Biagio Agostara; PierFranco Conte
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278).
Clinical breast cancer 2008;8(5):453-6.
2008: Maria Pia Sormani; Mar Tintorè; Marco Rovaris; Alex Rovira; Xavier Vidal; Paolo Bruzzi; Massimo Filippi; Xavier Montalban
Will Rogers phenomenon in multiple sclerosis.
Annals of neurology 2008;64(4):428-33.
2008: Lucia Del Mastro; B Dozin; Enrico Aitini; Tiziana Catzeddu; Editta Baldini; Antonio Contu; Antonio Durando; S Danese; Giovanna Cavazzini; Giuseppe Canavese; Paolo Bruzzi; Paolo Pronzato; Marco Venturini
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):299-307.
2007: Matteo Puntoni; Silvia Zanardi; Daniela Branchi; Silvia Bruno; Antonio Curotto; Marco Varaldo; Paolo Bruzzi; Andrea Decensi
Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(5):979-83.
2006: Andrea Bacigalupo; Teresa Lamparelli; Giovanni Barisione; Paolo Bruzzi; Stefano Guidi; Paolo Emilio Alessandrino; Paolo Di Bartolomeo; Rosi Oneto; Benedetto Bruno; Nicoletta Sacchi; Maria Teresa Van Lint; Alberto Bosi
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):560-5.
2005: Marco Venturini; Lucia Del Mastro; Enrico Aitini; Editta Baldini; Cinzia Caroti; Antonio Contu; Franco Testore; Fulvio Brema; Paolo Pronzato; Giovanna Cavazzini; Mario Roberto Sertoli; Giuseppe Canavese; Riccardo Rosso; Paolo Bruzzi
Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
Journal of the National Cancer Institute 2005;97(23):1724-33.
2005: Elisabetta Capello; Riccardo Saccardi; Alessandra Murialdo; Francesca Gualandi; Francesca Pagliai; A Bacigalupo; Alberto M Marmont; Antonio Uccelli; Matilde Inglese; Paolo Bruzzi; Maria Pia Sormani; Eleonora Cocco; G Meucci; Luca Massacesi; Antonio Bertolotto; A Lugaresi; Elisa Merelli; A Solari; Massimo Filippi; Giovanni Luigi Mancardi
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2005;26 Suppl 4():S200-3.
2005: Alessandra Gennari; PierFranco Conte; Riccardo Rosso; Cinzia Orlandini; Paolo Bruzzi
Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies.
Cancer 2005;104(8):1742-50.
2005: Giorgio Cocconi; Beatrice Di Blasio; Corrado Boni; Giancarlo Bisagni; Ermanno Rondini; Maria A Bella; Francesco Leonardi; Luisa Savoldi; C Vallisneri; Roberta Camisa; Paolo Bruzzi
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(9):1469-76.
2005: Lucia Del Mastro; Paolo Bruzzi; Guido Nicolò; Giovanna Cavazzini; Antonio Contu; M D'Amico; A Lavarello; F Testore; Bruno Castagneto; Enrico Aitini; Luisa Perdelli; Claudia Bighin; Riccardo Rosso; Marco Venturini
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients.
British journal of cancer 2005;93(1):7-14.
2005: Riccardo Saccardi; Giovanni Luigi Mancardi; Alessandra Solari; Alberto Bosi; Paolo Bruzzi; Paolo Di Bartolomeo; Amedea Donelli; Massimo Filippi; Angelo Guerrasio; Francesca Gualandi; Giorgio La Nasa; Alessandra Murialdo; Francesca Pagliai; Federico Papineschi; Barbara Scappini; Alberto M Marmont
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life.
Blood 2005;105(6):2601-7.
2005: Alberto Sobrero; Giovanni Luca Frassineti; Alfredo Falcone; L Dogliotti; Riccardo Rosso; Francesco Di Costanzo; F D Costanzo; Paolo Bruzzi
Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
British journal of cancer 2005;92(1):24-9.
2004: Pier Franco Conte; Valentina Guarneri; Paolo Bruzzi; Tiziana Prochilo; Barbara Salvadori; Angelo Bolognesi; Daniela Aldrighetti; Marco Venturini; Riccardo Rosso; Serafina Mammoliti; Flavio Carnino; Piergiorgio Giannessi; Massimo Costantini; Alfredo Moyano; Editta Baldini
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.
Cancer 2004;101(4):704-12.
2004: Editta Baldini; Tiziana Prochilo; Barbara Salvadori; A Bolognesi; Daniela Aldrighetti; Marco Venturini; Riccardo Rosso; Flavio Carnino; Luigi Gallo; Piergiorgio Giannessi; Pier Franco Conte; Cinzia Orlandini; Paolo Bruzzi
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety.
British journal of cancer 2004;91(1):45-9.
2004: Viviana Gismondi; Maurizio Meta; Luigina Bonelli; Paolo Radice; Paola Sala; Lucio Bertario; Alessandra Viel; Mara Fornasarig; Arrigo Arrigoni; Mattia Gentile; Maurizio Ponz de Leon; Luca Anselmi; Cristina Mareni; Paolo Bruzzi; Liliana Varesco
Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.
International journal of cancer. Journal international du cancer 2004;109(5):680-4.
2004: Claudio Viscoli; Marco Machetti; Paola Cappellano; Barbara Bucci; Paolo Bruzzi; Maria Teresa Van Lint; Andrea Bacigalupo
False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(6):913-6.
2004: Alessandra Gennari; Paolo Bruzzi; Cinzia Orlandini; Barbara Salvadori; Sara Donati; Elisabetta Landucci; Valentina Guarneri; Marianna Rondini; Sergio Ricci; PierFranco Conte
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy.
British journal of cancer 2004;90(5):962-7.
2003: Francesco Di Costanzo; Alberto Sobrero; Silvia Gasperoni; Luigi Dogliotti; Luca Frassineti; Alfredo Falcone; Rita Lionetto; Paolo Bruzzi; Gabriele Luppi; Luigi Gallo; PierFranco Conte; Alessandro Comandone; Daniele Turci; M Marzola; U Folco; Elisabetta Pfanner; M Mestriner; Corrado Boni; Costanza Galli; Maurizio Tonato; Riccardo Rosso
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(9):1365-72.
2003: Maria Pia Sormani; Rosi Oneto; Benedetto Bruno; M Fiorone; Teresa Lamparelli; Francesca Gualandi; Anna Maria Raiola; Alida Dominietto; Maria Teresa Van Lint; Francesco Frassoni; Paolo Bruzzi; Andrea Bacigalupo
A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell dose.
Bone marrow transplantation 2003;32(2):205-11.
2003: Massimo Costantini; Irene Higginson; Luca Boni; Maria Antonietta Orengo; Elsa Garrone; Franco Henriquet; Paolo Bruzzi
Effect of a palliative home care team on hospital admissions among patients with advanced cancer.
Palliative medicine 2003;17(4):315-21.
2003: Maria Pia Sormani; Paolo Bruzzi; K Beckmann; K Wagner; D H Miller; L Kappos; M Filippi
MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1b.
Neurology 2003;60(9):1462-6.
2003: Elio Castagnola; Luca Boni; Mareva Giacchino; Simone Cesaro; Luigi De Sio; Alberto Garaventa; Giulio Zanazzo; Pierfrancesco Biddau; Mario R Rossi; Francesco Schettini; Paolo Bruzzi; Claudio Viscoli
A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer.
The Pediatric infectious disease journal 2003;22(4):359-65.
2003: Massimo Costantini; Stefania Sciallero; Augusto Giannini; Beatrice Gatteschi; Paolo Rinaldi; Giuseppe Lanzanova; Luigina Bonelli; Tino Casetti; Elisabetta Bertinelli; Orietta Giuliani; Guido Castiglione; Paola Mantellini; Carlo Naldoni; Paolo Bruzzi
Interobserver agreement in the histologic diagnosis of colorectal polyps. the experience of the multicenter adenoma colorectal study (SMAC).
Journal of clinical epidemiology 2003;56(3):209-14.
2003: Editta Baldini; Giovanni Gardin; Piergiorgio Giannessi; Giuseppe Evangelista; Manuela Roncella; Tiziana Prochilo; Paola Collecchi; Riccardo Rosso; Rita Lionetto; Paolo Bruzzi; F Mosca; Pier Franco Conte
Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):227-32.
2002: Giorgio Cocconi; Beatrice Di Blasio; Corrado Boni; Giancarlo Bisagni; Guido Ceci; Ermanno Rondini; Maria A Bella; Francesco Leonardi; Luisa Savoldi; Roberta Camisa; Paolo Bruzzi
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Cancer 2002;95(2):228-35.
2002: Paolo Bruzzi
Objective response to treatment as a potential surrogate marker of survival in breast cancer.
Annals of the New York Academy of Sciences 2002;963():144-7.
2002: Maria Pia Sormani; Paolo Bruzzi; Giancarlo Comi; Massimo Filippi
MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients.
Neurology 2002;58(3):417-21.
2001: Giovanni Battista Ferrara; Andrea Bacigalupo; Teresa Lamparelli; Edoardo Lanino; Laura Delfino; A Morabito; Anna Maria Parodi; Cinzia Pera; Sarah Pozzi; Maria Pia Sormani; Paolo Bruzzi; D Bordo; M Bolognesi; Giuseppe Bandini; Andrea Bontadini; M Barbanti; Guido Frumento
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain.
Blood 2001;98(10):3150-5.
2001: Andrea Bacigalupo; Teresa Lamparelli; Paolo Bruzzi; Stefano Guidi; Paolo Emilio Alessandrino; Paolo Di Bartolomeo; Rosi Oneto; Benedetto Bruno; M Barbanti; Nicoletta Sacchi; Maria Teresa Van Lint; Alberto Bosi
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).
Blood 2001;98(10):2942-7.
2001: Hector Soto Parra; Lucia Tixi; Fiorenza Latteri; Sergio Bretti; Marco Alloisio; A Gravina; Rita Lionetto; Paolo Bruzzi; C Dani; Riccardo Rosso; M Cosso; Luca Balzarini; Armando Santoro; Andrea Ardizzoni
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP).
Cancer 2001;92(3):650-6.
2000: Alberto Sobrero; alberto zaniboni; Giovanni Luca Frassineti; Carlo Aschele; Alessandra Guglielmi; Rosa Giuliani; Alberto Ravaioli; C Lanfranco; Cinzia Caroti; E Arnoldi; Sandro Barni; Luigi Gallo; MA Pessi; Daniele Turci; Enrico Cortesi; Francesco Grossi; Luciano Frontini; Elena Piazza; Paolo Bruzzi; Roberto Labianca
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(11):1413-20.
2000: Andrea Decensi; Rosalba Torrisi; Silvia Bruno; M Costantini; Antonio Curotto; Guido Nicolò; B Malcangi; Laura Baglietto; G P Bruttini; Beatrice Gatteschi; Gabriella Rondanina; Marco Varaldo; Marjorie Perloff; Winfred F Malone; Paolo Bruzzi
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(10):1071-8.
1999: Silvia Bruno; Rosalba Torrisi; M Costantini; Laura Baglietto; Vincenzo Fontana; Beatrice Gatteschi; Giovanni Melioli; G Nicolo; Antonio Curotto; B Malcangi; G P Bruttini; Marco Varaldo; Paolo Bruzzi; Andrea Decensi
Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial.
Journal of cellular biochemistry 1999;76(2):311-21.
1999: Alessandra Gennari; Barbara Salvadori; Sara Donati; Carmelo Bengala; Cinzia Orlandini; Romano Danesi; Mario Del Tacca; Paolo Bruzzi; Pier Franco Conte
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3596-602.
1999: Stefania Sciallero; Luigina Bonelli; Hugo Aste; Tino Casetti; Elisabetta Bertinelli; S Bartolini; R Parri; Guido Castiglione; Paola Mantellini; Massimo Costantini; Carlo Naldoni; Paolo Bruzzi
Do patients with rectosigmoid adenomas 5 mm or less in diameter need total colonoscopy?
Gastrointestinal endoscopy 1999;50(3):314-21.
1998: Sergio Bretti; Alfredo Berruti; Luigi Dogliotti; Bruno Castagneto; R Bertulli; Pietro Spadaro; G Toscano; P Astorre; C Verusio; Rita Lionetto; Paolo Bruzzi; Armando Santoro
Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare Tumors.
Tumori 1998;84(5):558-61.
1998: Simona Pedemonte; Stefania Sciallero; Viviana Gismondi; P Stagnaro; R Biticchi; A Haeouaine; Luigina Bonelli; G Nicolŏ; Joanna Groden; Paolo Bruzzi; Hugo Aste; Liliana Varesco
Novel germline APC variants in patients with multiple adenomas.
Genes, chromosomes & cancer 1998;22(4):257-67.
1998: Giuseppe Canavese; Alessandra Catturich; Carlo Vecchio; Daniela Tomei; Marco Gipponi; Paolo Bruzzi; Fausto Badellino
Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1998;24(2):104-9.
1998: Giovanni Luigi Mancardi; Francesco Sardanelli; Roberto Carlo Parodi; E Melani; Elisabetta Capello; Matilde Inglese; A Ferrari; Maria Pia Sormani; C Ottonello; Fabrizio Levrero; Antonio Uccelli; Paolo Bruzzi
Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis.
Neurology 1998;50(4):1127-33.
1997: Stefania Sciallero; Massimo Costantini; Elisabetta Bertinelli; Guido Castiglione; P Onofri; Hugo Aste; Tino Casetti; Paola Mantellini; Lauro Bucchi; R Parri; L Boni; Luigina Bonelli; Beatrice Gatteschi; Giuseppe Lanzanova; P Rinaldi; Augusto Giannini; Carlo Naldoni; Paolo Bruzzi
Distal hyperplastic polyps do not predict proximal adenomas: results from a multicentric study of colorectal adenomas.
Gastrointestinal endoscopy 1997;46(2):124-30.
1997: Sergio Bertoglio; Pierluigi Percivale; Claudio Gambini; D Dicasa; Paolo Meszaros; Stefania Sciallero; Paolo Bruzzi; Fausto Badellino
Cytokeratin immunostaining reveals micrometastasis in negative hematoxylin-eosin lymph nodes of resected stage I-II (pT2-pT3) colorectal cancer.
Journal of chemotherapy (Florence, Italy) 1997;9(2):119-20.
1997: Paolo Bruzzi; L Dogliotti; Carlo Naldoni; Lauro Bucchi; Massimo Costantini; A Cicognani; M Torta; G F Buzzi; A Angeli
Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast.
BMJ (Clinical research ed.) 1997;314(7085):925-8.
1996: Marco Venturini; Andrea Michelotti; Lucia Del Mastro; L Gallo; Flavio Carnino; Ornella Garrone; Carmelo Tibaldi; N Molea; R C Bellina; Paolo Pronzato; P Cyrus; J Vinke; F Testore; M Guelfi; Rita Lionetto; Paolo Bruzzi; Pier Franco Conte; R Rosso
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(12):3112-20.
1996: Giovanni B Ratto; P Zino; S Mirabelli; P Minuti; R Aquilina; G Fantino; E Spessa; M Ponte; Paolo Bruzzi; Giovanni Melioli
A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinoma.
Cancer 1996;78(2):244-51.
1996: Marco Venturini; Paolo Bruzzi; Lucia Del Mastro; Ornella Garrone; Gianfilippo Bertelli; M Guelfi; S Pastorino; R Rosso; Mario Roberto Sertoli
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):764-73.
1995: Mario Roberto Sertoli; Paolo Bruzzi; Paolo Pronzato; Paola Queirolo; Domenico Amoroso; Lucia Del Mastro; Marco Venturini; A Vigani; Gianfilippo Bertelli; E Campora
Randomized cooperative study of perioperative chemotherapy in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2712-21.
1995: Lauro Bucchi; Massimo Costantini; G Buzzi; P Bravetti; Alessandro Cicognani; Mirella Torta; Carlo Naldoni; Luigi Dogliotti; Paolo Bruzzi
Wolfe's mammographic patterns in women with gross cystic disease of the breast.
Journal of clinical epidemiology 1995;48(7):969-76.
1995: Andrea Ardizzoni; G F Addamo; Editta Baldini; U Borghini; Luigi Portalone; Filippo De Marinis; R Lionetto; P F Conte; Paolo Bruzzi; MC Pennucci
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.
British journal of cancer 1995;71(1):115-9.
1994: Marco Venturini; Lucia Del Mastro; Giovanni Melioli; Enrico Balleari; Ornella Garrone; W Pasquetti; Caterina Bason; Riccardo Ghio; Paolo Bruzzi; R Rosso
Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy.
Cancer 1994;74(8):2300-6.
1994: Alberto Angeli; Luigi Dogliotti; Carlo Naldoni; Fabio Orlandi; B Puligheddu; P Caraci; Lauro Bucchi; Mirella Torta; Paolo Bruzzi
Steroid biochemistry and categorization of breast cyst fluid: relation to breast cancer risk.
The Journal of steroid biochemistry and molecular biology 1994;49(4-6):333-9.
1994: Stefania Sciallero; Luigina Bonelli; Elio Geido; L Lettieri; E Zeraschi; Paolo Bruzzi; Hugo Aste; Walter Giaretti
Lack of prognostic value of flow cytometric DNA content analysis in colorectal adenocarcinomas.
European journal of cancer (Oxford, England : 1990) 1994;30A(4):569.
1993: Andrea Ardizzoni; F Salvati; R Rosso; Paolo Bruzzi; Alessandra Rubagotti; MC Pennucci; G L Mariani; Filippo De Marinis; G Pallotta; Antonio Antilli
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force.
Cancer 1993;72(10):2929-35.
1993: Andrea Ardizzoni; Marco Venturini; L Crinò; Mario Roberto Sertoli; Paolo Bruzzi; MC Pennucci; G L Mariani; Ornella Garrone; S Bracarda; R Rosso
High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(5):687-92.
1992: Carlo Naldoni; Massimo Costantini; Luigi Dogliotti; Paolo Bruzzi; Lauro Bucchi; G Buzzi; Mirella Torta; Alberto Angeli
Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast.
Cancer research 1992;52(7):1791-5.
1992: Andrea Decensi; S Bruno; Walter Giaretti; Rosalba Torrisi; A Curotto; Beatrice Gatteschi; Elio Geido; Anna Polizzi; Massimo Costantini; Paolo Bruzzi
Activity of 4-HPR in superficial bladder cancer using DNA flow cytometry as an intermediate endpoint.
Journal of cellular biochemistry. Supplement 1992;16I():139-47.
1991: Beatrice Gatteschi; Massimo Costantini; Paolo Bruzzi; Franco Merlo; R Torcoli; G Nicolo
Univariate and multivariate analyses of the relationship between adenocarcinoma and solitary and multiple adenomas in colorectal adenoma patients.
International journal of cancer. Journal international du cancer 1991;49(4):509-12.
1990: E Campora; Editta Baldini; Alessandra Rubagotti; Silvana Chiara; Paolo Bruzzi; Mario Roberto Sertoli; R Rosso
Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.
Journal of chemotherapy (Florence, Italy) 1990;2(5):336-9.
1990: Francesco Boccardo; Alessandra Rubagotti; Paolo Bruzzi; M Cappellini; G Isola; italo nenci; A Piffanelli; A Scanni; Piero Sismondi; L Santi
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1310-20.
1990: Carlo Naldoni; Paolo Bruzzi; Lauro Bucchi; S Gordini; Mirella Torta; P Caraci; Fabio Orlandi
Cohort study of women affected by gross cystic disease. Correlation between cationic and hormonal composition of breast cyst fluid and the risk of breast cancer.
Annals of the New York Academy of Sciences 1990;586():272-5.
1990: Paolo Bruzzi; Lauro Bucchi; Massimo Costantini; Carlo Naldoni
Follow-up studies of patients with categorized breast cysts. Methodological issues.
Annals of the New York Academy of Sciences 1990;586():43-8.
1986: A Toti; S Agugiaro; D Amadori; G Buzzi; Paolo Bruzzi; E Buiatti; M C Capelli; Stefano Ciatto; E Delfino; E Foti
Breast cancer risk factors in Italian women: a multicentric case-control study.
Tumori 1986;72(3):241-9.
1981: V Pugliese; Beatrice Gatteschi; Hugo Aste; Guido Nicolò; F Munizzi; A Giacchero; Paolo Bruzzi
Value of multiple forceps biopsies in assessing the malignant potential of colonic polyps.
Tumori 1981;67(1):57-62.